Article Text

Download PDFPDF
Retinopathy of prematurity: keeping the status quo. A case series detailing the importance of keeping the current guidelines for screening
  1. Jonathan M Durnian1,
  2. David I Clark2
  1. 1St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK
  2. 2Department of Ophthalmology, University Hospital Aintree, Liverpool, UK
  1. Correspondence to Mr Jonathan Durnian, St Paul's Eye Unit, Link 8Z, Royal Liverpool University Hospital, Liverpool L7 9XP, UK; jondurnian{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Routine screening of premature infants for the development of retinopathy of prematurity (ROP) is one of the most significant advances in paediatric ophthalmology. The UK screening criteria, based on peer-reviewed articles, set the level of screening to catch as many affected babies as possible. Guidelines published by the Royal College of Ophthalmologists state evidence level B for screening all babies less than 31 weeks gestational age (GA) or less than 1251 g birth weight (BW) but as a good practice guide (GPP) to keep screening at 32 weeks or less and below 1501 g.1 The American Academy of Pediatrics guidelines states that infants with a BW less than 1500 g or GA of 32 weeks or less should be screened but also gives flexibility.2


View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles

  • PostScript
    Kamron N Khan Manir Ali Carmel Toomes Chris F Inglehearn John Bradbury